Cite
Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897.
MLA
Ambrosone, Christine B., et al. “Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 27, no. 30, Oct. 2009, pp. 4973–79. EBSCOhost, https://doi.org/10.1200/JCO.2009.21.8669.
APA
Ambrosone, C. B., Barlow, W. E., Reynolds, W., Livingston, R. B., Yeh, I.-T., Choi, J.-Y., Davis, W., Rae, J. M., Tang, L., Hutchins, L. R., Ravdin, P. M., Martino, S., Osborne, C. K., Lyss, A. P., Hayes, D. F., & Albain, K. S. (2009). Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 27(30), 4973–4979. https://doi.org/10.1200/JCO.2009.21.8669
Chicago
Ambrosone, Christine B, William E Barlow, Wanda Reynolds, Robert B Livingston, I-Tien Yeh, Ji-Yeob Choi, Warren Davis, et al. 2009. “Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 27 (30): 4973–79. doi:10.1200/JCO.2009.21.8669.